U.S. President Donald Trump rejected Director of National Intelligence Tulsi Gabbard’s earlier claim that Iran is not building a nuclear weapon, saying Friday, “She’s wrong.” Speaking in Morristown, New Jersey, Trump pushed back against Gabbard’s March testimony to Congress, in which she cited U.S. intelligence assessments indicating Iran was not pursuing a nuclear bomb.
Gabbard responded on social media platform X, clarifying her stance, stating that Iran could produce a nuclear weapon “within weeks to months” if it chose to proceed. She accused the media of misrepresenting her testimony and emphasized alignment with Trump’s firm stance against Iran's nuclear ambitions.
Tensions have escalated following Israeli Prime Minister Benjamin Netanyahu’s justification of recent airstrikes on Iran’s nuclear and military infrastructure, claiming Tehran is close to developing a warhead. Iran continues to deny any intent to build nuclear weapons, insisting its uranium enrichment is for peaceful purposes.
Despite Gabbard’s recent remarks, U.S. intelligence sources maintain that their assessment has not changed. They believe Iran would need up to three years to develop a nuclear warhead capable of hitting a target. However, some analysts warn that Iran could create a crude, untested device much sooner, though its effectiveness would be uncertain.
Gabbard, a known Trump ally, has previously criticized elements of the intelligence community, echoing Trump’s belief in the existence of a "deep state." Trump has a history of challenging U.S. intelligence, including their conclusion that Russia interfered in the 2016 election.
The White House stated that Trump will consider U.S. involvement in the Iran-Israel conflict in the coming weeks. The debate over Iran's nuclear capabilities continues to shape U.S. foreign policy and global security discussions.


Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Pentagon Ends Military Education Programs With Harvard University
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit
US Pushes Ukraine-Russia Peace Talks Before Summer Amid Escalating Attacks
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Trump Signs “America First Arms Transfer Strategy” to Prioritize U.S. Weapons Sales
U.S. Announces Additional $6 Million in Humanitarian Aid to Cuba Amid Oil Sanctions and Fuel Shortages
Japan Election 2026: Sanae Takaichi Poised for Landslide Win Despite Record Snowfall 



